Mediastinal B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Mediastinal B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma [Phase 1, Phase 2]
This document outlines an ongoing Phase 1/2 dose-escalation and dose-expansion trial of MDX2003 in multiple lymphoma types, including Walden…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Amping up With PemJAK [Phase 2]
A Phase 2 clinical trial of PemJAK for multiple lymphoma subtypes is currently recruiting, including non-Hodgkin lymphoma and Hodgkin lympho…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Bio-CAR-T BS Study
A clinical trial update indicates the Bio-CAR-T BS study is currently recruiting for diffuse large B-cell lymphoma, primary mediastinal B-ce…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL [Phase 2]
Phase 2 clinical trial evaluating obinutuzumab plus ICE chemotherapy for refractory or recurrent CD20-positive mature non-Hodgkin lymphoma i…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma [Phase 1]
A Phase 1 trial assessing sequential administration of CD19 CAR-NK cells followed by 7x19 CAR-T cells in relapsed/refractory B-cell lymphoma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.